2002•Chinese New Drugs JournalRequires access

Recent research progress in inhibitors of phosphodiesterase type 5, a new kind of anti-male erectile dysfunction agent

Jia Wang

Open publisher page 0 citations

Abstract

Male erectile dysfunction (ED) is a common clinical sexual dysfunction.Phosphodiesterases type 5(PDE5) is one of phosphodiesterases families that are particularly abundant in smooth muscle and blood platelet.Taking the PDE5 inhibitors raises the level of cGMP,induces dilation of smooth muscle,so that cures the male ED.Besides the sildenafil,there are also some other kinds of compounds that can inhibit PDE5. Maybe they will become selective and effective anti impotence drugs.In this paper,research progress in PDE5 inhibitors was reviewed.

About this research paper

What this paper is about

Male erectile dysfunction (ED) is a common clinical sexual dysfunction.Phosphodiesterases type 5(PDE5) is one of phosphodiesterases families that are particularly abundant in smooth muscle and blood platelet.Taking the PDE5 inhibitors raises the level of cGMP,induces dilation of smooth muscle,so that cures the male ED.Besides the sildenafil,there are also some other kinds of compounds that can inhibit PDE5. Maybe they will become selective and effective anti impotence drugs.In this paper,research progress in PDE5 inhibitors was reviewed.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Male erectile dysfunction (ED) is a common clinical sexual dysfunction.Phosphodiesterases type 5(PDE5) is one of phosphodiesterases families that are particularly abundant in smooth muscle and blood platelet.Taking the PDE5 inhibitors raises the level of cGMP,induces dilation of smooth muscle,so that cures the male ED.Besides the sildenafil,there are also some other kinds of compounds that can inhibit PDE5. Maybe they will become selective and effective anti impotence drugs.In this paper,research progress in PDE5 inhibitors was reviewed.

Key concepts: Sildenafil, cGMP-specific phosphodiesterase type 5, Erectile dysfunction, Phosphodiesterase, Smooth muscle, Medicine, Pharmacology, Phosphodiesterase 3

Related papers

Back to paper searchBrowse research topicsOriginal source
Recent research progress in inhibitors of phosphodiesterase type 5, a new kind of anti-male erectile dysfunction agent — Research Paper | ScholarLens